The Prognostic Impact of COVID-19 Incidence, the Effectiveness of SARS-CoV-2 Vaccine, and Factors that may Prevent Vaccination in Japanese Dialysis Patients
Not Applicable
- Conditions
- End-stage kidney disease under hemodialysis therapy
- Registration Number
- JPRN-UMIN000052167
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 365000
Inclusion Criteria
Not provided
Exclusion Criteria
In any survey, if the applicant is under 18 years of age. In addition, if the person is determined to lack the capacity to give informed consent, for example, if he/she has a diagnosis of dementia.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method COVID-19 morbidity and mortality after COVID-19 vaccination
- Secondary Outcome Measures
Name Time Method Cardiovascular disease incidence after COVID-19 morbidity Mortality after COVID-19 incidence Cardiovascular disease incidence after COVID-19 vaccination